Phathom Pharmaceuticals, Inc. Business Operations Contracts & Agreements
11 Contracts & Agreements
- Indemnification Agreements (1 contract)
- Management Agreements (1)
- Supply Agreements (9)
- Letter Agreement to Vonoprazan Commercial Supply Agreement, dated September 4, 2024, by and among Evonik Operations GmbH and the Registrant (Filed With SEC on November 7, 2024)
- First Amendment to the Commercial Supply Agreement, dated as of December 6, 2023, by and among Catalent Pharma Solutions, LLC and the Registrant (Filed With SEC on March 7, 2024)
- First Amendment to Vonoprazan Commercial Supply Agreement (Filed With SEC on August 10, 2023)
- Commercial Supply Agreement with Evonik Operations GmbH entered into on August 1, 2022 (Filed With SEC on November 8, 2022)
- Revenue Interest Financing Agreement, dated May 3, 2022, by and among NovaQuest Capital Management, Sagard Holding Manager, Hercules Capital and the Registrant (Filed With SEC on August 2, 2022)
- First Amendment to the Supply and Packaging Services Agreement, by and between Sandoz GmbH and the Registrant, dated December 4, 2021 (Filed With SEC on March 1, 2022)
- Commercial Supply Agreement with Catalent Pharma Solutions, LLC entered into on July 2, 2021 (Filed With SEC on August 10, 2021)
- Amendment No. 1 to Commercial Supply Agreement by and between Takeda Pharmaceuticals Company Limited and the Registrant, dated as of December 1, 2020 (Filed With SEC on March 30, 2021)
- Supply and Packaging Services Agreement, by and between Sandoz GmbH and the Registrant, dated December 30, 2020 (Filed With SEC on March 30, 2021)
- Commercial Supply Agreement, by and between Takeda Pharmaceuticals Company Limited and the Company, dated as of April 30, 2020 (Filed With SEC on August 6, 2020)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on September 30, 2019)
